FLESHNER NEIL E.

Director at POINT Biopharma Global Inc. · on record since Jun 30, 2021
Chief Medical Officer at POINT Biopharma Global Inc. · on record since Jun 30, 2021

Insider trading activity of FLESHNER NEIL E.

Transactions on record: 14; since Jun 30, 2021

Open-market buys: 0

Open-market sells: 1; $4.2M

Companies traded: 1; last filing Dec 27, 2023

Figures computed from official regulatory filings — .

Companies where FLESHNER NEIL E. has traded

POINT Biopharma Global Inc.14 tx · $4.2M · Dec 27, 2023

Track record of FLESHNER NEIL E.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of FLESHNER NEIL E.

Co-insiders of FLESHNER NEIL E.

BIOTECHNOLOGY VALUE FUND II LPPOINT Biopharma Global Inc.
BIOTECHNOLOGY VALUE FUND L PPOINT Biopharma Global Inc.
Biotechnology Value Trading Fund OS LPPOINT Biopharma Global Inc.
BVF GP HOLDINGS LLCPOINT Biopharma Global Inc.
BVF I GP LLCPOINT Biopharma Global Inc.
BVF II GP LLCPOINT Biopharma Global Inc.
BVF INC/ILPOINT Biopharma Global Inc.
BVF PARTNERS L P/ILPOINT Biopharma Global Inc.
BVF Partners OS Ltd.POINT Biopharma Global Inc.
DEMERS WILLIAM L.POINT Biopharma Global Inc.
GILMOUR MARGARET E.POINT Biopharma Global Inc.
GOODMAN JONATHAN R.POINT Biopharma Global Inc.
GOTTLIEB MICHAEL M.POINT Biopharma Global Inc.
Grau DanielPOINT Biopharma Global Inc.
GRAY MICHAELPOINT Biopharma Global Inc.
Hammond MatthewPOINT Biopharma Global Inc.
HOGUE GERALD L.POINT Biopharma Global Inc.
JENSEN JESSICA D.POINT Biopharma Global Inc.
KELLY JUSTYNAPOINT Biopharma Global Inc.
Kolchinsky PeterPOINT Biopharma Global Inc.
LAMPERT MARK NPOINT Biopharma Global Inc.
Lubner David CharlesPOINT Biopharma Global Inc.
Malik RajeshPOINT Biopharma Global Inc.
MARGOLIN YAELPOINT Biopharma Global Inc.
Martell Bridget APOINT Biopharma Global Inc.
MCCANN JOE A.POINT Biopharma Global Inc.
RA Capital Biotech Fund LPPOINT Biopharma Global Inc.
RA CAPITAL MANAGEMENT, LLCPOINT Biopharma Global Inc.
Shah Rajeev M.POINT Biopharma Global Inc.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	Other	-358	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	Other	-2,773,045	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	OtherD (derivative)	-60,234	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	Other	-233,171	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	OtherD (derivative)	-84,257	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Nov 2, 2023	Gift	-250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	Mar 30, 2023	AwardD (derivative)	84,257	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	May 26, 2022	Sell	-564,204	7.51 USD	$4.2M	SEC
POINT Biopharma Global Inc.Listing unverified	Mar 31, 2022	AwardD (derivative)	60,234	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	Jul 8, 2021	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	Jun 30, 2021	Award	233,171	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Jun 30, 2021	Award	3,587,249	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Jun 30, 2021	Award	358	—	n/a (No price was disclosed in the filing)	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	Other	-358	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	Other	-2,773,045	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	OtherD (derivative)	-60,234	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	OtherD (derivative)	-25,000	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	Other	-233,171	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Dec 27, 2023	OtherD (derivative)	-84,257	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Nov 2, 2023	Gift	-250,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	Mar 30, 2023	AwardD (derivative)	84,257	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	May 26, 2022	Sell	-564,204	7.51 USD	$4.2M	SEC
POINT Biopharma Global Inc.Listing unverified	Mar 31, 2022	AwardD (derivative)	60,234	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	Jul 8, 2021	AwardD (derivative)	25,000	0.00 USD	n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise))	SEC
POINT Biopharma Global Inc.Listing unverified	Jun 30, 2021	Award	233,171	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Jun 30, 2021	Award	3,587,249	—	n/a (No price was disclosed in the filing)	SEC
POINT Biopharma Global Inc.Listing unverified	Jun 30, 2021	Award	358	—	n/a (No price was disclosed in the filing)	SEC